NeurimmiRs: MicroRNAs in the neuroimmune interface

Trends in Molecular Medicine

Volumn 17, Issue 10, 2011, Pages 548-555

  Soreq, Hermona ^a   Wolf, Yochai ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MICRORNA; MICRORNA 124; MICRORNA 132; MICRORNA 146A; MICRORNA 155; MICRORNA 9; NEURIMMIR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AMYOTROPHIC LATERAL SCLEROSIS; AUTISM; CELL DIFFERENTIATION; CELL MATURATION; CENTRAL NERVOUS SYSTEM; CHROMOSOME DELETION 22Q11; DENDRITIC CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL CULTURE; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LONG TERM POTENTIATION; MOLECULAR INTERACTION; MONOCYTE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; RETT SYNDROME; REVIEW; SCHIZOPHRENIA;

ALZHEIMER DISEASE; ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MICRORNAS; MULTIPLE SCLEROSIS; NEURONS; PARKINSON DISEASE; SIGNAL TRANSDUCTION;

EID: 80053563273     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2011.06.009     Document Type: Review

References (62)

1. Flynt A.S., Lai E.C. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat. Rev. Genet. 2008, 9:831-842.
2. Tracey K.J. Understanding immunity requires more than immunology. Nat. Immunol. 2010, 11:561-564.
3. Glass C.K., et al. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
4. Boulanger L.M. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64:93-109.
5. O'Connell R.M., et al. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 2010, 10:111-122.
6. Li X., Jin P. Roles of small regulatory RNAs in determining neuronal identity. Nat. Rev. Neurosci. 2010, 11:329-338.
7. Eacker S.M., et al. Understanding microRNAs in neurodegeneration. Nat. Rev. Neurosci. 2009, 10:837-841.
8. Aronica E., et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 2010, 31:1100-1107.
9. Lukiw W.J., et al. An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 2008, 283:31315-31322.
10. Tufekci K.U., et al. MicroRNAs and multiple sclerosis. Autoimmune Dis. 2011, 10.4061/2011/807426.
11. Shlosberg D., et al. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 2010, 6:393-403.
12. Cheng L.C., et al. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 2009, 12:399-408.
13. Visvanathan J., et al. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 2007, 21:744-749.
14. Rajasethupathy P., et al. Characterization of small RNAs in aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 2009, 63:803-817.
15. Chandrasekar V., Dreyer J.L. microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol. Cell Neurosci. 2009, 42:350-362.
16. Ponomarev E.D., et al. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-[alpha]-PU.1 pathway. Nat. Med. 2011, 17:64-70.
17. Vreugdenhil E., et al. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 2009, 150:2220-2228.
18. * regulates REST and CoREST and is downregulated in Huntington's disease. J. Neurosci. 2008, 28:14341-14346.
19. Otaegi G., et al. MicroRNA miR-9 modifies motor neuron columns by a tuning regulation of FoxP1 levels in developing spinal cords. J. Neurosci. 2011, 31:809-818.
20. Haramati S., et al. miRNA malfunction causes spinal motor neuron disease. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:13111-13116.
21. Pietrzykowski A.Z., et al. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 2008, 59:274-287.
22. Bazzoni F., et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5282-5287.
23. Edbauer D., et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010, 65:373-384.
24. Le M.T., et al. MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol. Cell Biol. 2009, 29:5290-5305.
25. Ooi A.G., et al. MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:21505-21510.
26. O'Connell R.M., et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010, 33:607-619.
27. Kuhn D.E., et al. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J. Biol. Chem. 2010, 285:1529-1543.
28. Du C., et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009, 10:1252-1259.
29. Junker A., et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009, 132:3342-3352.
30. Rom S., et al. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J. 2010, 24:2292-2300.
31. Urdinguio R.G., et al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010, 5:656-663.
32. Szulwach K.E., et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol. 2010, 189:127-141.
33. Simon D.J., et al. The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell 2008, 133:903-915.
34. Krol J., et al. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
35. Shaked I., et al. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 2009, 31:965-973.
36. Gehrke S., et al. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 2010, 466:637-641.
37. Asikainen S., et al. Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models. J. Mol. Neurosci. 2010, 41:210-218.
38. Williams A.H., et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326:1549-1554.
39. Wayman G.A., et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9093-9098.
40. Magill S.T., et al. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20382-20387.
41. Meerson A., et al. Changes in brain MicroRNAs contribute to cholinergic stress reactions. J. Mol. Neurosci. 2010, 40:47-55.
42. Cheng H.Y., et al. microRNA modulation of circadian-clock period and entrainment. Neuron 2007, 54:813-829.
43. Pauley K.M., et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res. Ther. 2008, 10:R101.
44. Lagos D., et al. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell Biol. 2010, 12:513-519.
45. Badner J.A., Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry 2002, 7:405-411.
46. Stark K.L., et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 2008, 40:751-760.
47. Guimaraes-Sternberg C., et al. MicroRNA modulation of megakaryoblast fate involves cholinergic signaling. Leuk. Res. 2006, 30:583-595.
48. Benoit M.E., Tenner A.J. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J. Neurosci. 2011, 31:3459-3469.
49. Cogswell J.P., et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 2008, 14:27-41.
50. Ponomarev E.D., et al. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat. Med. 2011, 17:64-70.
51. Pocock J.M., Kettenmann H. Neurotransmitter receptors on microglia. Trends Neurosci. 2007, 30:527-535.
52. Kim A.H., et al. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr. Res. 2010, 124:183-191.
53. Im H.-I., et al. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat. Neurosci. 2010, 13:1120-1127.
54. Lusardi T.A., et al. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab. 2010, 30:744-756.
55. Younger S.T., Corey D.R. Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucl. Acids Res. 2011, 10.1093/nar/gkr155.
56. Shin C., et al. Expanding the microRNA targeting code: functional sites with centered pairing. Mol. Cell 2010, 38:789-802.
57. Hebert S.S., et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6415-6420.
58. Wang W.X., et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 2008, 28:1213-1223.
59. Boissonneault V., et al. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J. Biol. Chem. 2009, 284:1971-1981.
60. O'Neill L.A. Boosting the brain's ability to block inflammation via microRNA-132. Immunity 2009, 31:854-855.
61. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 2008, 9:219-230.
62. Ransohoff R.M., Cardona A.E. The myeloid cells of the central nervous system parenchyma. Nature 2010, 468:253-262.